Advanced Gastroesophageal Cancers — Expert Perspectives on Actual Patient Cases: Part 2 of 2
Oncology Today with Dr Neil Love
00:00
Matterhorn trial: FLOT plus DERVA benefit
Dr Janjigian presents Matterhorn design and shows FLOT plus derventolimab improved pathCR, EFS, and OS.
Play episode from 32:24
Transcript
